AU Stock MarketDetailed Quotes

ATXO Amplia Therapeutics Ltd

Watchlist

0.011
0.0000.00%

20min DelayNot Open Dec 22 16:00 AET

3.02MMarket Cap0.00P/E (Static)

Amplia Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 30, 2023

(FY)Mar 30, 2022

(FY)Mar 30, 2021

(FY)Mar 30, 2020

(FY)Mar 30, 2019

(FY)Mar 30, 2018

(FY)Mar 30, 2017

(FY)Mar 30, 2016

(FY)Mar 30, 2015

(FY)Mar 30, 2014

Operating cash flow (direct method)

Cash income from operating activities

65.22%1.88M

82.31%1.14M

625.47K

-88.35%218.12K

0.87%1.87M

123.06%1.86M

2,669.83%832.47K

7.62%30.06K

27.93K

Other cash income from operating activities

65.22%1.88M

82.31%1.14M

--625.47K

----

-88.35%218.12K

0.87%1.87M

123.06%1.86M

2,669.83%832.47K

7.62%30.06K

--27.93K

Cash paid

-30.98%-7.26M

-56.42%-5.54M

-69.46%-3.54M

-70.60%-2.09M

77.51%-1.23M

32.57%-5.45M

-43.87%-8.08M

-34.83%-5.62M

-150.05%-4.17M

-1.67M

Payments to suppliers for goods and services

-30.98%-7.26M

-56.42%-5.54M

-69.46%-3.54M

-70.60%-2.09M

77.51%-1.23M

32.57%-5.45M

-43.87%-8.08M

-34.83%-5.62M

-150.05%-4.17M

---1.67M

Direct dividend received

----

4.09%356

3.64%342

5.77%330

--312

Direct interest paid

----

0.00%-12

99.94%-12

---21.37K

Direct interest received

13,886.69%86.16K

-66.74%616

-41.36%1.85K

-84.43%3.16K

-28.81%20.28K

-54.92%28.49K

-10.52%63.2K

-55.41%70.62K

189.07%158.4K

--54.8K

Operating cash flow

-20.17%-5.29M

-50.95%-4.4M

-39.67%-2.92M

-111.47%-2.09M

72.18%-987.35K

42.41%-3.55M

-30.71%-6.16M

-18.52%-4.71M

-147.89%-3.98M

---1.6M

Investing cash flow

Cash flow from continuing investing activities

-119.30%-58.43K

-398.26%-26.64K

-5.35K

-270.94%-3.19K

104.01%1.87K

-19.12%-46.53K

-56.04%-39.06K

-2,869.28%-25.03K

-843

Net PPE purchase and sale

-22.42%-17.63K

-169.35%-14.4K

---5.35K

----

-270.94%-3.19K

104.01%1.87K

-19.12%-46.53K

-56.04%-39.06K

-2,869.28%-25.03K

---843

Net other investing changes

-233.28%-40.79K

---12.24K

----

Cash from discontinued investing activities

Investing cash flow

-119.30%-58.43K

-398.26%-26.64K

---5.35K

----

-270.94%-3.19K

104.01%1.87K

-19.12%-46.53K

-56.04%-39.06K

-2,869.28%-25.03K

---843

Financing cash flow

Cash flow from continuing financing activities

-100.49%-84.22K

369.22%17.19M

87.10%3.66M

16,223.93%1.96M

5.95%-12.14K

-100.15%-12.91K

117.46%8.72M

4.01M

9.43M

Net issuance payments of debt

----

--2.1M

----

--532.82K

Net common stock issuance

-99.86%21.23K

311.90%15.09M

87.10%3.66M

16,223.93%1.96M

5.95%-12.14K

-100.15%-12.91K

117.46%8.72M

--4.01M

----

--8.9M

Interest paid (cash flow from financing activities)

---40.8K

----

Net other financing activities

---64.65K

----

Cash from discontinued financing activities

Financing cash flow

-100.49%-84.22K

369.22%17.19M

87.10%3.66M

16,223.93%1.96M

5.95%-12.14K

-100.15%-12.91K

117.46%8.72M

--4.01M

----

--9.43M

Net cash flow

Beginning cash position

690.33%14.61M

66.81%1.85M

-10.70%1.11M

-44.33%1.24M

-61.32%2.23M

80.07%5.76M

-21.72%3.2M

-48.51%4.09M

6,691.71%7.94M

--116.93K

Current changes in cash

-142.57%-5.43M

1,620.41%12.76M

670.33%741.7K

87.03%-130.05K

71.83%-1M

-242.02%-3.56M

436.17%2.51M

81.37%-745.62K

-151.15%-4M

--7.83M

Effect of exchange rate changes

43,108.56%80.43K

86.75%-187

48.62%-1.41K

-119.07%-2.75K

-43.94%14.4K

-54.28%25.68K

139.38%56.17K

-195.14%-142.65K

21,217.18%149.93K

---710

End cash Position

-36.64%9.26M

690.33%14.61M

66.81%1.85M

-10.70%1.11M

-44.33%1.24M

-61.32%2.23M

80.07%5.76M

-21.72%3.2M

-48.51%4.09M

--7.94M

Free cash from

-20.17%-5.31M

-51.16%-4.42M

-39.93%-2.92M

-110.79%-2.09M

72.12%-990.54K

42.77%-3.55M

-30.61%-6.21M

-18.75%-4.75M

-149.32%-4M

---1.61M

Accounting Standards

US-GAAP

	(FY)Mar 30, 2023	(FY)Mar 30, 2022	(FY)Mar 30, 2021	(FY)Mar 30, 2020	(FY)Mar 30, 2019	(FY)Mar 30, 2018	(FY)Mar 30, 2017	(FY)Mar 30, 2016	(FY)Mar 30, 2015	(FY)Mar 30, 2014
Operating cash flow (direct method)
Cash income from operating activities	65.22%1.88M	82.31%1.14M	625.47K		-88.35%218.12K	0.87%1.87M	123.06%1.86M	2,669.83%832.47K	7.62%30.06K	27.93K
Other cash income from operating activities	65.22%1.88M	82.31%1.14M	--625.47K	----	-88.35%218.12K	0.87%1.87M	123.06%1.86M	2,669.83%832.47K	7.62%30.06K	--27.93K
Cash paid	-30.98%-7.26M	-56.42%-5.54M	-69.46%-3.54M	-70.60%-2.09M	77.51%-1.23M	32.57%-5.45M	-43.87%-8.08M	-34.83%-5.62M	-150.05%-4.17M	-1.67M
Payments to suppliers for goods and services	-30.98%-7.26M	-56.42%-5.54M	-69.46%-3.54M	-70.60%-2.09M	77.51%-1.23M	32.57%-5.45M	-43.87%-8.08M	-34.83%-5.62M	-150.05%-4.17M	---1.67M
Direct dividend received	----	----	----	----	----	----	4.09%356	3.64%342	5.77%330	--312
Direct interest paid	----	----	----	----	----	----	----	0.00%-12	99.94%-12	---21.37K
Direct interest received	13,886.69%86.16K	-66.74%616	-41.36%1.85K	-84.43%3.16K	-28.81%20.28K	-54.92%28.49K	-10.52%63.2K	-55.41%70.62K	189.07%158.4K	--54.8K
Operating cash flow	-20.17%-5.29M	-50.95%-4.4M	-39.67%-2.92M	-111.47%-2.09M	72.18%-987.35K	42.41%-3.55M	-30.71%-6.16M	-18.52%-4.71M	-147.89%-3.98M	---1.6M
Investing cash flow
Cash flow from continuing investing activities	-119.30%-58.43K	-398.26%-26.64K	-5.35K		-270.94%-3.19K	104.01%1.87K	-19.12%-46.53K	-56.04%-39.06K	-2,869.28%-25.03K	-843
Net PPE purchase and sale	-22.42%-17.63K	-169.35%-14.4K	---5.35K	----	-270.94%-3.19K	104.01%1.87K	-19.12%-46.53K	-56.04%-39.06K	-2,869.28%-25.03K	---843
Net other investing changes	-233.28%-40.79K	---12.24K	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-119.30%-58.43K	-398.26%-26.64K	---5.35K	----	-270.94%-3.19K	104.01%1.87K	-19.12%-46.53K	-56.04%-39.06K	-2,869.28%-25.03K	---843
Financing cash flow
Cash flow from continuing financing activities	-100.49%-84.22K	369.22%17.19M	87.10%3.66M	16,223.93%1.96M	5.95%-12.14K	-100.15%-12.91K	117.46%8.72M	4.01M		9.43M
Net issuance payments of debt	----	--2.1M	----	----	----	----	----	----	----	--532.82K
Net common stock issuance	-99.86%21.23K	311.90%15.09M	87.10%3.66M	16,223.93%1.96M	5.95%-12.14K	-100.15%-12.91K	117.46%8.72M	--4.01M	----	--8.9M
Interest paid (cash flow from financing activities)	---40.8K	----	----	----	----	----	----	----	----	----
Net other financing activities	---64.65K	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-100.49%-84.22K	369.22%17.19M	87.10%3.66M	16,223.93%1.96M	5.95%-12.14K	-100.15%-12.91K	117.46%8.72M	--4.01M	----	--9.43M
Net cash flow
Beginning cash position	690.33%14.61M	66.81%1.85M	-10.70%1.11M	-44.33%1.24M	-61.32%2.23M	80.07%5.76M	-21.72%3.2M	-48.51%4.09M	6,691.71%7.94M	--116.93K
Current changes in cash	-142.57%-5.43M	1,620.41%12.76M	670.33%741.7K	87.03%-130.05K	71.83%-1M	-242.02%-3.56M	436.17%2.51M	81.37%-745.62K	-151.15%-4M	--7.83M
Effect of exchange rate changes	43,108.56%80.43K	86.75%-187	48.62%-1.41K	-119.07%-2.75K	-43.94%14.4K	-54.28%25.68K	139.38%56.17K	-195.14%-142.65K	21,217.18%149.93K	---710
End cash Position	-36.64%9.26M	690.33%14.61M	66.81%1.85M	-10.70%1.11M	-44.33%1.24M	-61.32%2.23M	80.07%5.76M	-21.72%3.2M	-48.51%4.09M	--7.94M
Free cash from	-20.17%-5.31M	-51.16%-4.42M	-39.93%-2.92M	-110.79%-2.09M	72.12%-990.54K	42.77%-3.55M	-30.61%-6.21M	-18.75%-4.75M	-149.32%-4M	---1.61M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall